Jazz Pharmaceuticals Hits High On Gentium Acquisition

Late Thursday, Jazz said it agreed to buy Gentium for $57 a share, or about $1 billion.

http://news.investors.com/technology/122013-683707-jazz-gentium-buyout-wins-analyst-approval.htm?ref=HPLNews